UM

Browse/Search Results:  1-10 of 14 Help

Selected(0)Clear Items/Page:    Sort:
Exploiting demand-side heterogeneous flexible resources in risk management of power system frequency Journal article
Yao, Yu, Song, Yong Hua, Ye, Cheng Jin, Ding, Yi, Zhao, Yu Ming. Exploiting demand-side heterogeneous flexible resources in risk management of power system frequency[J]. SCIENCE CHINA-TECHNOLOGICAL SCIENCES, 2024, 67(5), 16120-1627.
Authors:  Yao, Yu;  Song, Yong Hua;  Ye, Cheng Jin;  Ding, Yi;  Zhao, Yu Ming
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.4/4.3 | Submit date:2024/05/16
Aggregation Method  Demand-side Heterogenous Flexible Resources  Mixed Integer Second-order Cone Programming  Performance Curve  Risk Management Of Power System Frequency  
Total flavonoids of Astragalus protects glomerular filtration barrier in diabetic kidney disease Journal article
Pei‑Yu Liu, Kin‑Fong Hong, Ya‑Di Liu, Zhong‑Yan Sun, Ting‑Ting Zhao, Xu‑Ling Li, Chi‑Chou Lao, Shu‑Feng Tan, Hai‑Ying Zhang, Yong‑Hua Zhao, Ying Xie, You‑Hua Xu. Total flavonoids of Astragalus protects glomerular filtration barrier in diabetic kidney disease[J]. Chinese Medicine, 2024, 19(1), 27.
Authors:  Pei‑Yu Liu;  Kin‑Fong Hong;  Ya‑Di Liu;  Zhong‑Yan Sun;  Ting‑Ting Zhao; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:5.3/5.5 | Submit date:2024/04/03
Astragalus  Diabetic Kidney Disease  Flavonoids  Proteinuria  
The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao Journal article
Hui Mo, Man-Fei Zhou, Edmundo Patricio Lopes Lao, Ka-Kei Chan, On-Na Lai, Man-In Ho, Kin-Wa Wong, Ka-Meng Ho, Kin-Tim Sio, Keng-Lam Fong, Yong-Hua Zhao, Seng-Ip Cheang, Iek-Long Lo. The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao[J]. Chinese Medicine, 2024, 19(1), 15.
Authors:  Hui Mo;  Man-Fei Zhou;  Edmundo Patricio Lopes Lao;  Ka-Kei Chan;  On-Na Lai; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.3/5.5 | Submit date:2024/04/03
Covid-19  Chinese Proprietary Medicine  Huoxiang Zhengqi Capsule  Lianhua Qingwen Capsule  
Quality Evaluation of Xiasangju Granules Based on HPTLC Identification and UHPLC-QAM-TIRS Determination Conference paper
Yang, Qi, Zhao, Yong-Hua, Chen, Xiao-Jia. Quality Evaluation of Xiasangju Granules Based on HPTLC Identification and UHPLC-QAM-TIRS Determination[C], 2023.
Authors:  Yang, Qi;  Zhao, Yong-Hua;  Chen, Xiao-Jia
Favorite |  | Submit date:2023/12/11
Xiasangju Granules  Flavonoids  Phenolic Acids  Hptlc Identification  Uhplc-qam-tirs Method  Quality Evaluation  
Advances in the Application of Perovskite Materials Journal article
Lixiu Zhang, Luyao Mei, Kaiyang Wang, Yinhua Lv, Shuai Zhang, Yaxiao Lian, Xiaoke Liu, Zhiwei Ma, Guanjun Xiao, Qiang Liu, Shuaibo Zhai, Shengli Zhang, Gengling Liu, Ligang Yuan, Bingbing Guo, Ziming Chen, Keyu Wei, Aqiang Liu, Shizhong Yue, Guangda Niu, Xiyan Pan, Jie Sun, Yong Hua, Wu-Qiang Wu, Dawei Di, Baodan Zhao, Jianjun Tian, Zhijie Wang, YangYang, Liang Chu, Mingjian Yuan, Haibo Zeng, Hin-Lap Yip, Keyou Yan, Wentao Xu, Lu Zhu, Wenhua Zhang, Guichuan Xing, Feng Gao, Liming Ding. Advances in the Application of Perovskite Materials[J]. Nano-Micro Letters, 2023, 15(1), 177.
Authors:  Lixiu Zhang;  Luyao Mei;  Kaiyang Wang;  Yinhua Lv;  Shuai Zhang; et al.
Favorite | TC[WOS]:122 TC[Scopus]:127  IF:31.6/26.0 | Submit date:2023/08/03
Neuromorphic Devices  Optoelectronic Devices  Perovskites  Pressure-induced Emission  
Preclinical studies of licorice in ulcerative colitis: A systematic review with meta-analysis and network pharmacology Journal article
Peng-De Lu, Meng-Chen Yuan, Xing-Ping Quan, Jin-Fen Chen, Yong-Hua Zhao. Preclinical studies of licorice in ulcerative colitis: A systematic review with meta-analysis and network pharmacology[J]. JOURNAL OF ETHNOPHARMACOLOGY, 2022, 296, 115444.
Authors:  Peng-De Lu;  Meng-Chen Yuan;  Xing-Ping Quan;  Jin-Fen Chen;  Yong-Hua Zhao
Favorite | TC[WOS]:12 TC[Scopus]:13  IF:4.8/4.8 | Submit date:2022/07/29
Licorice  Ulcerative Colitis  Preclinical Study  Systematic Review  
Overview of therapeutic potentiality of Angelica sinensis for ischemic stroke Journal article
Han, Yan, Chen, Ying, Zhang, Qian, Liu, Bo Wen, Yang, Li, Xu, You Hua, Zhao, Yong Hua. Overview of therapeutic potentiality of Angelica sinensis for ischemic stroke[J]. PHYTOMEDICINE, 2021, 90, 153652.
Authors:  Han, Yan;  Chen, Ying;  Zhang, Qian;  Liu, Bo Wen;  Yang, Li; et al.
Favorite | TC[WOS]:25 TC[Scopus]:31  IF:6.7/6.2 | Submit date:2021/12/08
Angelica Sinensis  Ischemic Stroke  Mechanisms  Therapeutic Effects  
Targeting NF-κB pathway for treating ulcerative colitis: Comprehensive regulatory characteristics of Chinese medicines Journal article
Lu,Peng De, Zhao,Yong Hua. Targeting NF-κB pathway for treating ulcerative colitis: Comprehensive regulatory characteristics of Chinese medicines[J]. Chinese Medicine, 2020, 15(1).
Authors:  Lu,Peng De;  Zhao,Yong Hua
Adobe PDF | Favorite | TC[WOS]:86 TC[Scopus]:88  IF:5.3/5.5 | Submit date:2021/03/02
Characteristics  Chinese Medicines  Nf-κb  Ulcerative Colitis  
Shengui Sansheng Pulvis maintains blood-brain barrier integrity by vasoactive intestinal peptide after ischemic stroke Journal article
Xia,Zhen Yan, Luo,Cheng, Liu,Bo Wen, Bian,Xi Qing, Li,Yang, Pang,Ai Ming, Xu,You Hua, Tan,Hong Mei, Zhao,Yong Hua. Shengui Sansheng Pulvis maintains blood-brain barrier integrity by vasoactive intestinal peptide after ischemic stroke[J]. Phytomedicine, 2020, 67(153158).
Authors:  Xia,Zhen Yan;  Luo,Cheng;  Liu,Bo Wen;  Bian,Xi Qing;  Li,Yang; et al.
Favorite | TC[WOS]:15 TC[Scopus]:15  IF:6.7/6.2 | Submit date:2021/03/02
Blood-brain Barrier  Ischemic Stroke  Shengui Sansheng Pulvis  Vasoactive Intestinal Peptide  
Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke Journal article
Zhao,Yong hua. Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke[J]. Chinese Journal of Integrative Medicine, 2019, 25(10), 723-727.
Authors:  Zhao,Yong hua
Favorite | TC[WOS]:2 TC[Scopus]:5  IF:2.2/2.3 | Submit date:2021/03/02
Chinese Medicines  Combination Treatment  Ischemic Stroke  Mesenchymal Stem Cell